The tariff classification of Mometasone Furoate (CAS-83919-23-7), imported in bulk form, from India
Reasoning
The tariff classification of Mometasone Furoate (CAS-83919-23-7), imported in bulk form, from India
Cite this ruling
CBP Ruling G85002 (2937220000): The tariff classification of Mometasone Furoate (CAS-83919-23-7), imported in bulk form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 293722
The tariff classification of Mirtazapine (CAS-61337-67-5), Mometasone Furoate (CAS-83919-23-7), Nifedipine (CAS-21829-25-4), Orphenadrine Citrate (CAS-83-98-7) and Oxandrolone (CAS-53-39-4), imported in bulk form, from Spain and Italy
The tariff classification of Fluticasone Propionate (CAS-80474-14-2), Gabapentin (CAS-60142-96-3), Glipizide (CAS-29094-61-9), Glyburide (CAS-10238-21-8), and Halobetasol Propionate (CAS-66852-54-8), imported in bulk form, from Italy
The tariff classification of Diclofenac (CAS-15307-86-5), Dipivefrin (CAS-52365-63-6), Disopyramide (CAS-3737-09-5), Fluocinonide (CAS-356-12-7), and Fluocinolone Acetonide (CAS-67-73-2), all imported in bulk form, from Taiwan, Japan, Japan, Italy, and Italy, respectively
The tariff classification of Betamethasone Acetate (CAS-987-24-6), imported in bulk form, from Spain
The tariff classification of Acetaminophen (CAS-103-90-2), Albuterol Sulfate (CAS-51022-70-9); Alprazolam (CAS-28981-97-7); Beclomethasone (CAS-4419-39-0); and Bromocriptine Mesylate (CAS-22260-51-1), all imported in bulk form, from Taiwan, India, India, Italy and Italy, respectively